News
The success of PRAISE-U is dependent on clear and transparent communication between actors. As such, all publications related to the project can be reviewed and shared to promote full understanding of the project and the sharing of important data between stakeholders.
PRAISE-U project presents to the National Societies in Noordwijk
Read more about the progress made in Noordwijk.
Implications of EU Council recommendations on Prostate Cancer Screening
Read about how changes to the EU Council recommendations are shaping PCa screening in Europe.
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
Read about the role of PRAISE-U.
Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe
This is a systematic review aimed to provide a contemporary overview of the costs and benefits of Prostate Cancer screening programmes.
Understanding the Barriers to Prostate Cancer Population-based Early Detection Programmes: The PRAISE-U BEST Survey
Read more about the diverse barriers to PCa screening faced by countries across Europe
Why is there a need to re-think Prostate Cancer early detection?
Read this abstract on the evidence on the need for PCa Early detection.
Why is there a need to re-think Prostate Cancer early detection?
Read this abstract on the evidence on the need for PCa Early detection.
Systematic review on the cost-effectiveness of prostate cancer screening in Europe.
Read this systematic review of peer-reviewed literature on the cost-effectiveness of PCa screening.
PRAISE U – a new era in risk-based screening for Prostate Cancer in the EU
Read this abstract discussing the PRAISE-U project
February 2024 PRAISE-U updates
Read articles published on updates from PRAISE-U
Article: July 2023 Praise-U Update
Read about the progress of the Praise-U project
Press Release
Read about the launch of PRAISE-U and what can be expected from the project.
About PRAISE-U
In direct partnership with a network of consortium members, PRAISE-U works to encourage early detection and diagnosis of prostate cancer through customised and risk-based screening programmes.